Mirum Pharmaceuticals
$103.8
37
+$0.58+0.56% Today
Statistics
Day High
105.11
Day Low
101.79
52W High
105.11
52W Low
36.88
Volume
887,138
Avg. Volume
767,622
Mkt Cap
5.33B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
11MarExpected
Expected EPS
0.042222
Actual EPS
N/A
Financials
-26.1%Profit Margin
Unprofitable673.78MRevenue
-175.88MNet Income
Analyst Ratings
$100.80Average Price Target
The highest estimate is 140.00.
From 10 ratings within the last 6 months. This is not an investment recommendation.
From 10 ratings within the last 6 months. This is not an investment recommendation.
Buy 80%
Hold 20%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow MIRM. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Vertex Pharmaceuticals
VRTX
Mkt Cap109.11B
Alnylam Pharmaceuticals
ALNY
Mkt Cap60.25B
Gilead Sciences
GILD
Mkt Cap148.78B
Abbvie
ABBV
Mkt Cap385.18B
Pfizer
PFE
Mkt Cap140.15B
Novartis
NVS
Mkt Cap237.61B
Merck
MRK
Mkt Cap214.76B
Astrazeneca
AZN
Mkt Cap256.58B
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
About
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the treatment of Alagille syndrome and biliary atresia disease. It also develops Volixibat drug for treatment of intrahepatic cholestasis of pregnancy and primary sclerosing cholangitis. Mirum Pharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Foster City, California.
Show more...
CEO
Mr. Christopher Peetz
Employees
334
Country
US
ISIN
US6047491013
Listings
0 Comments
Share your thoughts
FAQ
What is Mirum Pharmaceuticals stock price today?▼
The current price of MIRM is $103.8 USD — it has increased by +0.56% in the past 24 hours. Watch Mirum Pharmaceuticals stock price performance more closely on the chart.
What is Mirum Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Mirum Pharmaceuticals stocks are traded under the ticker MIRM.
Is Mirum Pharmaceuticals stock price growing?▼
MIRM stock has risen by +7.1% compared to the previous week, the month change is a +32.96% rise, over the last year Mirum Pharmaceuticals has showed a +112.36% increase.
What is Mirum Pharmaceuticals market cap?▼
Today Mirum Pharmaceuticals has the market capitalization of 5.33B
When is the next Mirum Pharmaceuticals earnings date?▼
Mirum Pharmaceuticals is going to release the next earnings report on March 11, 2026.
What were Mirum Pharmaceuticals earnings last quarter?▼
MIRM earnings for the last quarter are 0.05 USD per share, whereas the estimation was -0.14 USD resulting in a +135.67% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Mirum Pharmaceuticals revenue for the last year?▼
Mirum Pharmaceuticals revenue for the last year amounts to 673.78M USD.
What is Mirum Pharmaceuticals net income for the last year?▼
MIRM net income for the last year is -175.88M USD.
How many employees does Mirum Pharmaceuticals have?▼
As of February 02, 2026, the company has 334 employees.
In which sector is Mirum Pharmaceuticals located?▼
Mirum Pharmaceuticals operates in the Health Care sector.
When did Mirum Pharmaceuticals complete a stock split?▼
Mirum Pharmaceuticals has not had any recent stock splits.
Where is Mirum Pharmaceuticals headquartered?▼
Mirum Pharmaceuticals is headquartered in Foster City, US.